Investing.com - Incyte reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Incyte announced earnings per share of $0.1 on revenue of $862.85M. Analysts polled by Investing.com EPS of $0.5678 on revenue of $813.38M.
Incyte 's are down 0.07% and is trading at $73.35 , still down 22.22% from its 52 week high of $94.30 set on Tuesday, February 9, 2021.
Incyte follows other major Healthcare sector earnings this month
Incyte's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar